Publications by authors named "Lisa Sherman"

Claim this Profile
A
Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial.
Gerard J Criner, Frederick M Lang, Robert L Gottlieb, Kusum S Mathews, Tisha S Wang, Lisa Sherman

Am J Respir Crit Care Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictability of peripheral lymphocyte reduction of novel S1P1 agonists by in vitro GPCR signaling profile.
Han Xu, Michele McElvain, Mike Fiorino, Brad Henkle, Lisa Sherman

J Biomol Screen· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of triazolopyridazinones as potent p38α inhibitors.
Brad Herberich, Claire Jackson, Ryan P Wurz, Liping H Pettus, Lisa Sherman

Bioorg Med Chem Lett· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum haptoglobin concentrations in dairy cattle with lameness due to claw disorders.
Billy I Smith, Johannes Kauffold, Lisa Sherman

Vet J· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of pyridazinopyridinones as potent and selective p38 mitogen-activated protein kinase inhibitors.
Bin Wu, Hui-Ling Wang, Liping Pettus, Ryan P Wurz, Elizabeth M Doherty, Lisa Sherman

J Med Chem· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and evaluation of 7-alkyl-1,5-bis-aryl-pyrazolopyridinones as highly potent, selective, and orally efficacious inhibitors of p38alpha mitogen-activated protein kinase.
Liping H Pettus, Ryan P Wurz, Shimin Xu, Brad Herberich, Bradley Henkle, Lisa Sherman

J Med Chem· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Part 2: Structure-activity relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38alpha mitogen-activated protein kinase.
Ryan P Wurz, Liping H Pettus, Bradley Henkle, Lisa Sherman, Matthew Plant

Bioorg Med Chem Lett· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Part 1: Structure-Activity Relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38alpha mitogen-activated protein kinase.
Ryan P Wurz, Liping H Pettus, Shimin Xu, Bradley Henkle, Lisa Sherman

Bioorg Med Chem Lett· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-amino-7-phthalazinylbenzoisoxazoles as a novel class of potent, selective, and orally available inhibitors of p38alpha mitogen-activated protein kinase.
Liping H Pettus, Shimin Xu, Guo-Qiang Cao, Partha P Chakrabarti, Robert M Rzasa, Lisa Sherman

J Med Chem· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of highly selective and potent p38 inhibitors based on a phthalazine scaffold.
Brad Herberich, Guo-Qiang Cao, Partha P Chakrabarti, James R Falsey, Liping Pettus, Lisa Sherman

J Med Chem· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis